Qaytona is free while it's in beta — Get started

Ingredients

Hexarelin

Examorelin

Snapshot

IndicationsContraindications
  • Growth hormone release1
  • Growth in short children2
  • IGF-I support2
  • Age-related growth hormone decline3, 4
  • Left ventricular performance5
  • Tested competitive athletes6

Hexarelin (examorelin) is a synthetic hexapeptide that stimulates growth hormone release as a growth hormone secretagogue.1 The World Anti-Doping Agency (WADA) lists it among prohibited growth hormone-releasing peptides, at all times in and out of competition.6 Interest centers on raising growth hormone and insulin-like growth factor I (IGF-I), studied in short prepubertal children and in healthy older adults with age-related decline in growth hormone release. Acute cardiac effects have also been examined in healthy men.5

Evidence is short-term and physiologic. Single doses raised growth hormone in a dose-dependent way in healthy men, while chronic injection partly blunted the response and left IGF-I unchanged.1 In a 2015 study giving each peptide nasally to a single volunteer, hexarelin was extensively metabolized, with a metabolite detectable after the parent compound cleared; the work informs anti-doping detection, not clinical use.7 In a 2025 warning letter, a product listed as hexarelin acetate was found misbranded because its listed active ingredient was a different peptide.8

Single doses raised cortisol, adrenocorticotropic hormone, and prolactin in healthy volunteers, although chronic injection did not show sustained over-stimulation of the pituitary-adrenal axis or prolactin.9, 10

Last updated October 17, 2026. Read how we make monographs.

In the full monograph

35 sources, 28 studies

  • When to useThe situations practitioners use it for, each with the reason and the study behind it.
  • SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
  • InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
  • Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
  • How it worksWhat it is and how it works in the body, in plain terms.
  • Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
  • Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
  • Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.

Sources

  1. 1Growth hormone-releasing activity of hexarelin in humans. A dose-response study.pubmed.ncbi.nlm.nih.govImbimbo, Mant, Edwards et al. · European journal of clinical pharmacology · 1994 · Pubmed
  2. 2Intranasal administration of the GHRP hexarelin accelerates growth in short children.pubmed.ncbi.nlm.nih.govLaron, Frenkel, Deghenghi et al. · Clinical endocrinology · 1995 · Pubmed
  3. 3Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.pubmed.ncbi.nlm.nih.govArvat, Gianotti, Grottoli et al. · The Journal of clinical endocrinology and metabolism · 1994 · Pubmed
  4. 4Oestrogen replacement does not restore the reduced GH-releasing activity of Hexarelin, a synthetic hexapeptide, in post-menopausal women.pubmed.ncbi.nlm.nih.govArvat, Gianotti, Broglio et al. · European journal of endocrinology · 1997 · Pubmed
  5. 5Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans.pubmed.ncbi.nlm.nih.govBisi, Podio, Valetto et al. · Journal of endocrinological investigation · 1999 · Pubmed
  6. 6US statusfda.govWhat the FDA (its lists of substances nominated for pharmacy compounding, and Drugs@FDA) and the World Anti-Doping Agency's Prohibited List say about this ingredient, in their own words. A legal status, not evidence of benefit or harm
  7. 7Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin.pubmed.ncbi.nlm.nih.govSemenistaya, Zvereva, Thomas et al. · Drug testing and analysis · 2015 · Pubmed
  8. 8FDA actionsfda.govFDA warning letters, import alerts and Pharmacy Compounding Advisory Committee documents that name this ingredient, in the FDA's words. Findings about products sold and a regulator's review, not evidence of harm from the ingredient itself
  9. 9Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin in humans.pubmed.ncbi.nlm.nih.govBenso, Gottero, Prodam et al. · Journal of endocrinological investigation · 2003 · Pubmed
  10. 10The effect of chronic hexarelin administration on the pituitary-adrenal axis and prolactin.pubmed.ncbi.nlm.nih.govRahim, O'Neill, Shalet · Clinical endocrinology · 1999 · Pubmed